New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 31, 2012
09:00 EDTDGXQuest Diagnostics sells OralDNA labs to Access Genetics
Quest Diagnostics announced that it has sold substantially all of the assets of its OralDNA(R) Labs salivary-diagnostics business to Access Genetics, a clinical laboratory with advanced molecular diagnostics test development and information technology capabilities. Terms of the transaction were not disclosed.
News For DGX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 30, 2015
10:00 EDTDGXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:38 EDTDGXQuest Diagnostics downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo downgraded Quest Diagnostics (DGX) to its sell-equivalent Underperform rating saying the charges associated with the company's Invigorate savings initiative should not be viewed as one-time by investors. Wells thinks the initiative will need to be ongoing as Quest's margins are declining. It keeps a $60-$65 price target range for shares. The diagnostic testing company closed yesterday up 52c to $71.09. Quest’s main competitor is LabCorp (LH).
January 29, 2015
12:02 EDTDGXQuest Diagnostics downgraded to Hold from Buy at Craig-Hallum
Subscribe for More Information
07:13 EDTDGXQuest Diagnostics sees 2015 adjusted EPS $4.70-$4.85, consensus $4.43
Subscribe for More Information
07:11 EDTDGXQuest Diagnostics increases quarterly dividend 15% to 38c
Subscribe for More Information
07:10 EDTDGXQuest Diagnostics reports Q4 adjusted EPS $1.08, consensus $1.05
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use